Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-21

Clinical Trial Update: Effect of Danazol on Endometrial αvβ3 Integrin Expression in Patients With Unexplained Recurrent Implantation Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Danazol's effect on endometrial αvβ3 integrin expression in patients with unexplained recurrent implantation failure; trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danazol (danazol)

Snippet

Sponsor: Ain Shams University | Conditions: Unexplained Infertility | Phase 3 | Status: COMPLETED